Using our AI model trained on historical data, we generated a 12‑month forecast for TransMedics Group Inc. (TMDX) stock. The model estimates a median target price of 114.03—ranging from a low of 86.86 to a high of 142.01—which suggests an increase of 64.24% compared to the current price of 69.43.